|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product revenue | |||||
| Other revenue | |||||
| Total revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Change in fair value of warrant liability | |||||
| Interest income, net | |||||
| Other expense | |||||
| Income before taxes | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain on investment adjustments | |||||
| Foreign currency translation adjustments | |||||
| Total comprehensive income (loss) | |||||
| Common share data: | |||||
| Basic income (loss) per common share (in dollars per share) | |||||
| Weighted average number of basic shares outstanding (in shares) | |||||
| Diluted income (loss) per common share (in dollars per share) | |||||
| Weighted average number of diluted shares outstanding (in shares) | |||||
Loading...